1431 related articles for article (PubMed ID: 17903666)
1. Immune response in leukodystrophies.
Eichler F; Van Haren K
Pediatr Neurol; 2007 Oct; 37(4):235-44. PubMed ID: 17903666
[TBL] [Abstract][Full Text] [Related]
2. Transplant outcomes in leukodystrophies.
Orchard PJ; Tolar J
Semin Hematol; 2010 Jan; 47(1):70-8. PubMed ID: 20109614
[TBL] [Abstract][Full Text] [Related]
3. Advances and pitfalls of cell therapy in metabolic leukodystrophies.
Miranda CO; Brites P; Mendes Sousa M; Teixeira CA
Cell Transplant; 2013; 22(2):189-204. PubMed ID: 23006656
[TBL] [Abstract][Full Text] [Related]
4. Hematopoietic stem cell gene therapy in Hurler syndrome, globoid cell leukodystrophy, metachromatic leukodystrophy and X-adrenoleukodystrophy.
Cartier N; Aubourg P
Curr Opin Mol Ther; 2008 Oct; 10(5):471-8. PubMed ID: 18830923
[TBL] [Abstract][Full Text] [Related]
5. Leukodystrophies with late disease onset: an update.
Köhler W
Curr Opin Neurol; 2010 Jun; 23(3):234-41. PubMed ID: 20216214
[TBL] [Abstract][Full Text] [Related]
6. Leukodystrophies underlying cryptic spastic paraparesis: frequency and phenotype in 76 patients.
Müller vom Hagen J; Karle KN; Schüle R; Krägeloh-Mann I; Schöls L
Eur J Neurol; 2014 Jul; 21(7):983-8. PubMed ID: 24698313
[TBL] [Abstract][Full Text] [Related]
7. Immunopathogenesis of adrenoleukodystrophy: current understanding.
Hudspeth MP; Raymond GV
J Neuroimmunol; 2007 Jan; 182(1-2):5-12. PubMed ID: 17125847
[TBL] [Abstract][Full Text] [Related]
8. Progress in leukodystrophies with zebrafish.
Shih HY; Raas Q; Bonkowsky JL
Dev Growth Differ; 2024 Jan; 66(1):21-34. PubMed ID: 38239149
[TBL] [Abstract][Full Text] [Related]
9. Microglia damage precedes major myelin breakdown in X-linked adrenoleukodystrophy and metachromatic leukodystrophy.
Bergner CG; van der Meer F; Winkler A; Wrzos C; Türkmen M; Valizada E; Fitzner D; Hametner S; Hartmann C; Pfeifenbring S; Stoltenburg-Didinger G; Brück W; Nessler S; Stadelmann C
Glia; 2019 Jun; 67(6):1196-1209. PubMed ID: 30980503
[TBL] [Abstract][Full Text] [Related]
10. Leukodystrophy incidence in Germany.
Heim P; Claussen M; Hoffmann B; Conzelmann E; Gärtner J; Harzer K; Hunneman DH; Köhler W; Kurlemann G; Kohlschütter A
Am J Med Genet; 1997 Sep; 71(4):475-8. PubMed ID: 9286459
[TBL] [Abstract][Full Text] [Related]
11. [Transplant of hematopoietic stem cells in X-linked adrenoleukodystrophy].
Madero L; Sevilla J
Rev Neurol; 2001 Aug 1-15; 33(3):225-7. PubMed ID: 11588714
[TBL] [Abstract][Full Text] [Related]
12. Hematopoietic Stem Cell Transplantation to Treat Leukodystrophies: Clinical Practice Guidelines from the Hunter's Hope Leukodystrophy Care Network.
Page KM; Stenger EO; Connelly JA; Shyr D; West T; Wood S; Case L; Kester M; Shim S; Hammond L; Hammond M; Webb C; Biffi A; Bambach B; Fatemi A; Kurtzberg J
Biol Blood Marrow Transplant; 2019 Dec; 25(12):e363-e374. PubMed ID: 31499213
[TBL] [Abstract][Full Text] [Related]
13. Epilepsy in children with leukodystrophies.
Zhang J; Ban T; Zhou L; Ji H; Yan H; Shi Z; Cao B; Jiang Y; Wang J; Wu Y
J Neurol; 2020 Sep; 267(9):2612-2618. PubMed ID: 32388833
[TBL] [Abstract][Full Text] [Related]
14. Recent Advancements in the Diagnosis and Treatment of Leukodystrophies.
Bradbury AM; Ream MA
Semin Pediatr Neurol; 2021 Apr; 37():100876. PubMed ID: 33892849
[TBL] [Abstract][Full Text] [Related]
15. General anesthesia safety in progressive leukodystrophies: A retrospective study of patients with Krabbe disease and metachromatic leukodystrophy.
Bascou NA; Marcos MC; Beltran Quintero ML; Roosen-Marcos MC; Cladis FP; Poe MD; Escolar ML
Paediatr Anaesth; 2019 Oct; 29(10):1053-1059. PubMed ID: 31359511
[TBL] [Abstract][Full Text] [Related]
16. Blood to brain to the rescue.
Proia RL; Wu YP
J Clin Invest; 2004 Apr; 113(8):1108-10. PubMed ID: 15085187
[TBL] [Abstract][Full Text] [Related]
17. Scope and Burden of Non-Standard of Care Hematopoietic Stem Cell Transplantation in Pediatric Leukodystrophy Patients.
Bonkowsky JL; Wilkes J; Shyr DC
J Child Neurol; 2018 Dec; 33(14):882-887. PubMed ID: 30261790
[TBL] [Abstract][Full Text] [Related]
18. Early recognition of patients with leukodystrophies.
Modesti NB; Evans SH; Jaffe N; Vanderver A; Gavazzi F
Curr Probl Pediatr Adolesc Health Care; 2022 Dec; 52(12):101311. PubMed ID: 36470810
[TBL] [Abstract][Full Text] [Related]
19. Disease specific therapies in leukodystrophies and leukoencephalopathies.
Helman G; Van Haren K; Bonkowsky JL; Bernard G; Pizzino A; Braverman N; Suhr D; Patterson MC; Ali Fatemi S; Leonard J; van der Knaap MS; Back SA; Damiani S; Goldman SA; Takanohashi A; Petryniak M; Rowitch D; Messing A; Wrabetz L; Schiffmann R; Eichler F; Escolar ML; Vanderver A;
Mol Genet Metab; 2015 Apr; 114(4):527-36. PubMed ID: 25684057
[TBL] [Abstract][Full Text] [Related]
20. Animal models of leukodystrophy: a new perspective for the development of therapies.
Rutherford HA; Hamilton N
FEBS J; 2019 Nov; 286(21):4176-4191. PubMed ID: 31520449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
